Haleos Labs Limited (BOM:540679)
India flag India · Delayed Price · Currency is INR
1,313.80
-4.20 (-0.32%)
At close: Feb 12, 2026

Haleos Labs Company Description

Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products.

It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025.

Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.

Haleos Labs Limited
CountryIndia
Founded1990
IndustryPharmaceutical Preparations
Employees592
CEOTalluri Veera Venkata Murthy

Contact Details

Address:
Plot No. 19-III
Hyderabad, 500096
India
Phone91 40 6628 8888
Websitesmslife.in

Stock Details

Ticker Symbol540679
ExchangeBombay Stock Exchange
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Talluri Veera Venkata MurthyChief Executive Officer
Nadella PrasadChief Financial Officer
Lakshminarayana SomisettyChief Operating Officer